Jing Xu

Active Investor

Vice President, Head of Global Strategy at Sciwind Biosciences

Singapore, Central Singapore Community Development Council

Jing Xu, Vice President, Head of Global Strategy at Sciwind Biosciences is an active investor based in Singapore, Central Singapore Community Development Council. This profile covers what Jing Xu backs, at which stage, and how founders can reach out in 2026.

Investor type: VCPE
Stages: SeedSeries ASeries BLate Stage Venture
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected DevicesManufacturing & IndustrialGaming & Entertainment
Location: Singapore, Central Singapore Community Development Council
Typical check: $2M
Past investments: 22

Notable investments

Zhangkong TangniaobingAohuaStarna TherapeuticsMedilink TherapeuticsImmuneOnco BiopharmaCytek BiosciencesBaixing Pingan YaofangABclonalAnsun BioPharmaSciwind BiosciencesHiFiBiOChemLex

How to reach Jing Xu

Angels and operators like Jing Xu reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Jing Xu invest in?

Jing Xu invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.